Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2024

Open Access 01-12-2024 | Chronic Obstructive Lung Disease | Research

Outcomes of coronary artery bypass grafting (CABG) in patients with OSA-COPD overlap syndrome versus COPD alone: an analysis of US Nationwide Inpatient Sample

Authors: Yen-Liang Yeh, Chien-Ming Lai, Hui-Pu Liu

Published in: BMC Pulmonary Medicine | Issue 1/2024

Login to get access

Abstract

Background

Obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) are associated with unfavorable outcomes following coronary artery bypass grafting (CABG). The purpose of this study was to compare in-hospital outcomes of patients with COPD alone versus OSA-COPD overlap after CABG.

Methods

Data of adults ≥ 18 years old with COPD who received elective CABG between 2005 and 2018 were extracted from the US Nationwide Inpatient Sample (NIS). Patients were divided into two groups: with OSA-COPD overlap and COPD alone. Propensity score matching (PSM) was employed to balance the between-group characteristics. Logistic and linear regression analyses determined the associations between study variables and inpatient outcomes.

Results

After PSM, data of 2,439 patients with OSA-COPD overlap and 9,756 with COPD alone were analyzed. After adjustment, OSA-COPD overlap was associated with a significantly increased risk of overall postoperative complications (adjusted odd ratio [aOR] = 1.12, 95% confidence interval [CI]: 95% CI: 1.01–1.24), respiratory failure/prolonged mechanical ventilation (aOR = 1.27, 95%CI: 1.14–1.41), and non-routine discharge (aOR = 1.16, 95%CI: 1.03–1.29), and AKI (aOR = 1.14, 95% CI: 1.00-1.29). Patients with OSA-COPD overlap had a lower risk of in-hospital mortality (adjusted odd ratio [aOR] = 0.53, 95% CI: 0.35–0.81) than those with COPD only. Pneumonia or postoperative atrial fibrillation (AF) risks were not significantly different between the 2 groups. Stratified analyses revealed that, compared to COPD alone, OSA-COPD overlap was associated with increased respiratory failure/prolonged mechanical ventilation risks among patients ≥ 60 years, and both obese and non-obese subgroups. In addition, OSA-COPD overlap was associated with increased risk of AKI among the older and obese subgroups.

Conclusion

In US adults who undergo CABG, compared to COPD alone, those with OSA-COPD are at higher risks of non-routine discharge, AKI, and respiratory failure/prolonged mechanical ventilation, but a lower in-hospital mortality. No increased risk of AF was noted.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jacobs JP, Shahian DM, D’Agostino RS, Jacobs ML, Kozower BD, Badhwar V, et al. The society of thoracic surgeons national database 2017 annual report. Ann Thorac Surg. 2017;104(6):1774–81.CrossRefPubMed Jacobs JP, Shahian DM, D’Agostino RS, Jacobs ML, Kozower BD, Badhwar V, et al. The society of thoracic surgeons national database 2017 annual report. Ann Thorac Surg. 2017;104(6):1774–81.CrossRefPubMed
2.
go back to reference Fox JP, Suter LG, Wang K, Wang Y, Krumholz HM, Ross JS. Hospital-based, acute care use among patients within 30 days of discharge after coronary artery bypass surgery. Ann Thorac Surg. 2013;96(1):96–104.CrossRefPubMedPubMedCentral Fox JP, Suter LG, Wang K, Wang Y, Krumholz HM, Ross JS. Hospital-based, acute care use among patients within 30 days of discharge after coronary artery bypass surgery. Ann Thorac Surg. 2013;96(1):96–104.CrossRefPubMedPubMedCentral
3.
go back to reference Montrief T, Koyfman A, Long B. Coronary artery bypass graft surgery complications: a review for emergency clinicians. Am J Emerg Med. 2018;36(12):2289–97.CrossRefPubMed Montrief T, Koyfman A, Long B. Coronary artery bypass graft surgery complications: a review for emergency clinicians. Am J Emerg Med. 2018;36(12):2289–97.CrossRefPubMed
4.
go back to reference Dimeling G, Bakaeen L, Khatri J, Bakaeen FG. CABG: when, why, and how? Cleve Clin J Med. 2021;88(5):295–303.CrossRefPubMed Dimeling G, Bakaeen L, Khatri J, Bakaeen FG. CABG: when, why, and how? Cleve Clin J Med. 2021;88(5):295–303.CrossRefPubMed
5.
go back to reference Mayor S. Keep within target range of blood oxygen levels, new guideline recommends. BMJ. 2017;357:j2354.CrossRefPubMed Mayor S. Keep within target range of blood oxygen levels, new guideline recommends. BMJ. 2017;357:j2354.CrossRefPubMed
6.
7.
go back to reference Soguel Schenkel N, Burdet L, de Muralt B, Fitting JW. Oxygen saturation during daily activities in chronic obstructive pulmonary disease. Eur Respir J. 1996;9(12):2584–9.CrossRefPubMed Soguel Schenkel N, Burdet L, de Muralt B, Fitting JW. Oxygen saturation during daily activities in chronic obstructive pulmonary disease. Eur Respir J. 1996;9(12):2584–9.CrossRefPubMed
9.
go back to reference GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the global burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585–96.CrossRef GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the global burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585–96.CrossRef
10.
go back to reference Heilbrunn ES, Ssentongo P, Chinchilli VM, Oh J, Ssentongo AE. Sudden death in individuals with obstructive sleep apnoea: a systematic review and meta-analysis. BMJ Open Respir Res. 2021;8(1):e000656.CrossRefPubMedPubMedCentral Heilbrunn ES, Ssentongo P, Chinchilli VM, Oh J, Ssentongo AE. Sudden death in individuals with obstructive sleep apnoea: a systematic review and meta-analysis. BMJ Open Respir Res. 2021;8(1):e000656.CrossRefPubMedPubMedCentral
11.
go back to reference Poh TY, Mac Aogáin M, Chan AK, Yii AC, Yong VF, Tiew PY, et al. Understanding COPD-overlap syndromes. Expert Rev Respir Med. 2017;11(4):285–98.CrossRefPubMed Poh TY, Mac Aogáin M, Chan AK, Yii AC, Yong VF, Tiew PY, et al. Understanding COPD-overlap syndromes. Expert Rev Respir Med. 2017;11(4):285–98.CrossRefPubMed
12.
go back to reference Brennan M, McDonnell MJ, Walsh SM, Gargoum F, Rutherford R. Review of the prevalence, pathogenesis and management of OSA-COPD overlap. Sleep Breath. 2022;26(4):1551–60.CrossRefPubMed Brennan M, McDonnell MJ, Walsh SM, Gargoum F, Rutherford R. Review of the prevalence, pathogenesis and management of OSA-COPD overlap. Sleep Breath. 2022;26(4):1551–60.CrossRefPubMed
13.
go back to reference Amra B, Niknam N, Sadeghi MM, Rabbani M, Fietze I, Penzel T. Obstructive sleep apnea and postoperative complications in patients undergoing coronary artery bypass graft surgery: a need for preventive strategies. Int J Prev Med. 2014;5(11):1446–51.PubMedPubMedCentral Amra B, Niknam N, Sadeghi MM, Rabbani M, Fietze I, Penzel T. Obstructive sleep apnea and postoperative complications in patients undergoing coronary artery bypass graft surgery: a need for preventive strategies. Int J Prev Med. 2014;5(11):1446–51.PubMedPubMedCentral
14.
go back to reference Gali B, Glasgow AE, Greason KL, Johnson RL, Albright RC, Habermann EB. Postoperative outcomes of patients with obstructive sleep apnea undergoing cardiac surgery. Ann Thorac Surg. 2020;110(4):1324–32.CrossRefPubMed Gali B, Glasgow AE, Greason KL, Johnson RL, Albright RC, Habermann EB. Postoperative outcomes of patients with obstructive sleep apnea undergoing cardiac surgery. Ann Thorac Surg. 2020;110(4):1324–32.CrossRefPubMed
15.
go back to reference Zhao H, Li L, Yang G, Gong J, Ye L, Zhi S, et al. Postoperative outcomes of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass grafting surgery: a meta-analysis. Med (Baltim). 2019;98(6):e14388.CrossRef Zhao H, Li L, Yang G, Gong J, Ye L, Zhi S, et al. Postoperative outcomes of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass grafting surgery: a meta-analysis. Med (Baltim). 2019;98(6):e14388.CrossRef
16.
go back to reference Szylińska A, Kotfis K, Listewnik M, Brykczyński M, Marra A, Rotter I. The burden of chronic obstructive pulmonary disease in open heart surgery-a retrospective cohort analysis of postoperative complications: STROBE compliant. Med (Baltim). 2020;99(13):e19675.CrossRef Szylińska A, Kotfis K, Listewnik M, Brykczyński M, Marra A, Rotter I. The burden of chronic obstructive pulmonary disease in open heart surgery-a retrospective cohort analysis of postoperative complications: STROBE compliant. Med (Baltim). 2020;99(13):e19675.CrossRef
17.
go back to reference Desai R, Sachdeva S, Jain A, Rizvi B, Fong HK, Raina J, et al. Comparison of percutaneous coronary intervention outcomes among patients with obstructive sleep apnea, chronic obstructive pulmonary disease overlap, and pickwickian syndrome (obesity hypoventilation syndrome). Cureus. 2022;14(5):e24816.PubMedPubMedCentral Desai R, Sachdeva S, Jain A, Rizvi B, Fong HK, Raina J, et al. Comparison of percutaneous coronary intervention outcomes among patients with obstructive sleep apnea, chronic obstructive pulmonary disease overlap, and pickwickian syndrome (obesity hypoventilation syndrome). Cureus. 2022;14(5):e24816.PubMedPubMedCentral
18.
go back to reference Mehaffey JH, Hawkins RB, Byler M, Charles EJ, Fonner C, Kron I, et al. Cost of individual complications following coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2018;155(3):875–e821.CrossRefPubMed Mehaffey JH, Hawkins RB, Byler M, Charles EJ, Fonner C, Kron I, et al. Cost of individual complications following coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2018;155(3):875–e821.CrossRefPubMed
29.
go back to reference Tzoumas A, Nagraj S, Tasoudis P, Arfaras-Melainis A, Palaiodimos L, Kokkinidis DG, et al. Atrial fibrillation following coronary artery bypass graft: where do we stand? Cardiovasc Revasc Med. 2022;40:172–9.CrossRefPubMed Tzoumas A, Nagraj S, Tasoudis P, Arfaras-Melainis A, Palaiodimos L, Kokkinidis DG, et al. Atrial fibrillation following coronary artery bypass graft: where do we stand? Cardiovasc Revasc Med. 2022;40:172–9.CrossRefPubMed
31.
go back to reference Simons SO, Elliott A, Sastry M, Hendriks JM, Arzt M, Rienstra M, et al. Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective. Eur Heart J. 2021;42(5):532–40.CrossRefPubMed Simons SO, Elliott A, Sastry M, Hendriks JM, Arzt M, Rienstra M, et al. Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective. Eur Heart J. 2021;42(5):532–40.CrossRefPubMed
32.
go back to reference Romiti GF, Corica B, Pipitone E, Vitolo M, Raparelli V, Basili S, et al. Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients. Eur Heart J. 2021;42(35):3541–54.CrossRefPubMed Romiti GF, Corica B, Pipitone E, Vitolo M, Raparelli V, Basili S, et al. Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients. Eur Heart J. 2021;42(35):3541–54.CrossRefPubMed
Metadata
Title
Outcomes of coronary artery bypass grafting (CABG) in patients with OSA-COPD overlap syndrome versus COPD alone: an analysis of US Nationwide Inpatient Sample
Authors
Yen-Liang Yeh
Chien-Ming Lai
Hui-Pu Liu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2024
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-024-02994-y

Other articles of this Issue 1/2024

BMC Pulmonary Medicine 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine